"Right to try" law signed
June 02, 2018
As noted by many media outlets, the president signed legislation known as "right to try," where terminally ill patients will supposedly have better access to experimental medications. The move appears controversial, with various groups either diminishing the impact of the legislation or highlighting that it might make things worse for patients.
CBS News published a piece that gives an overview of the landscape before the legislation: although there was no federal legislation, 38 states already have similar laws. In addition, FDA already had a program in place where it approved of the vast majority of requests for experimental medication. Others have noted that easier access might mean that patients suffer more unsafe medications.